Lumida
/CRMD
⌘K
CorMedix Inc

CorMedix Inc

CRMD
$8.42USD+1.57%+0.13 today

MARKET CAP

660.6M

P/E (TTM)

3.8x

FWD P/E

635.0x

DAY RANGE

$8 – $9

52W RANGE

$6
$15

AI Summary

Stalk
Sell NowMedium

CRMD is entrenched in a Stage 4 decline with a clear sequence of lower highs and lower lows. Short-term trend and EMAs are sloping downward, and price is extended below moving averages without signs of exhaustion. The medium-term bias remains bearish, unsupported by any mean-reversion eligibility, justifying an immediate sell initiation into resistance at the declining EMA regime.

  • Q1 2026 net revenue $127.4M, up 226% YoY, led by DefendCath
  • FY26 revenue guidance raised to $325–345M from $300–320M
  • 80% of shipments concentrated with U.S. Renal Care, posing client risk
Full analysis →
Insider Trades37 trades
DateSideTickerInsiderRoleSharesPriceMkt Cap52W High52W LowValue% ChgRuleAI View
Jan 23, 2026SellCRMDKaufman Beth ZelnickChief Legal Officer8,803$7.27$660.6M-43.72%+37.47%$64.0K-3.64%Sell Now
Jan 23, 2026SellCRMDSusan BlumChief Financial Officer9,767$7.27$660.6M-43.72%+37.47%$71.0K-6.85%Sell Now
Jan 23, 2026SellCRMDElizabeth HurlburtChief Operating Officer10,778$7.27$660.6M-43.72%+37.47%$78.4K-4.25%Sell Now
Jan 23, 2026SellCRMDJoseph TodiscoChief Executive Officer27,306$7.27$660.6M-43.72%+37.47%$198.5K-3.77%Sell Now
Jan 12, 2026SellCRMDElizabeth HurlburtChief Operating Officer5,794$7.15$660.6M-43.72%+37.47%$41.4K-3.49%Sell Now
Jan 12, 2026SellCRMDJoseph TodiscoChief Executive Officer69,667$5.43$660.6M-43.72%+37.47%$378.2K-0.54%Sell Now
Jan 2, 2026SellCRMDElizabeth HurlburtChief Operating Officer10,895$12.16$660.6M-43.72%+37.47%$132.5K-6.16%Sell Now
Jan 2, 2026SellCRMDKaufman Beth ZelnickChief Legal Officer11,333$12.16$660.6M-43.72%+37.47%$137.8K-6.28%Sell Now
Dec 18, 2025SellCRMDJoseph TodiscoChief Executive Officer60,000$8.21$660.6M-43.72%+37.47%$492.9K+0.00%Sell Now
Sep 12, 2025SellCRMDJoseph TodiscoChief Executive Officer100,000$8.23$660.6M-43.72%+37.47%$823.5K+0.00%Sell Now
Sep 9, 2025SellCRMDElizabeth HurlburtChief Operating Officer107,994$7.32$660.6M-43.72%+37.47%$790.1K+0.00%Sell Now
Sep 9, 2025SellCRMDKaufman Beth ZelnickChief Legal Officer100,000$8.35$660.6M-43.72%+37.47%$835.3K+0.00%Sell Now
Aug 29, 2025SellCRMDElizabeth HurlburtChief Operating Officer8,424$14.83$660.6M-43.72%+37.47%$124.9K-4.54%Sell Now
Aug 29, 2025SellCRMDKaufman Beth ZelnickChief Legal Officer8,880$14.83$660.6M-43.72%+37.47%$131.7K-4.69%Sell Now
May 10, 2025SellCRMDJoseph TodiscoChief Executive Officer21,225$11.66$660.6M-43.72%+37.47%$247.5K-4.00%Sell Now
Apr 1, 2025BuyCRMDJoseph TodiscoChief Executive Officer59,170$3.38$660.6M-43.72%+37.47%$200.0K+6.49%Sell Now
Jan 17, 2025SellCRMDJoseph TodiscoChief Executive Officer23,977$12.17$660.6M-43.72%+37.47%$291.8K-4.84%Sell Now
Jan 10, 2025SellCRMDErin MistryEVP, Chief Commercial Officer5,689$11.19$660.6M-43.72%+37.47%$63.7K-5.33%Sell Now
Jan 10, 2025SellCRMDElizabeth HurlburtEVP5,790$11.19$660.6M-43.72%+37.47%$64.8K-4.76%Sell Now
Jan 10, 2025SellCRMDMatthew T DavidChief Financial Officer6,515$11.19$660.6M-43.72%+37.47%$72.9K-6.40%Sell Now
Jan 10, 2025SellCRMDJoseph TodiscoChief Executive Officer17,829$11.19$660.6M-43.72%+37.47%$199.5K-5.47%Sell Now
Jan 2, 2025SellCRMDErin MistryEVP, Chief Commercial Officer7,830$8.22$660.6M-43.72%+37.47%$64.4K-6.84%Sell Now
Jan 2, 2025SellCRMDMatthew T DavidChief Financial Officer8,648$8.22$660.6M-43.72%+37.47%$71.1K-7.83%Sell Now
Jan 2, 2025SellCRMDElizabeth HurlburtEVP11,378$8.22$660.6M-43.72%+37.47%$93.5K-8.56%Sell Now
Jan 2, 2025SellCRMDKaufman Beth ZelnickChief Legal Officer11,844$8.22$660.6M-43.72%+37.47%$97.4K-9.01%Sell Now
Dec 12, 2024SellCRMDKaufman Beth ZelnickChief Legal Officer6,044$8.77$660.6M-43.72%+37.47%$53.0K-6.04%Sell Now
Dec 12, 2024SellCRMDKaufman Beth ZelnickChief Legal Officer6,044$8.77$660.6M-43.72%+37.47%$53.0K-12.09%Sell Now
Nov 14, 2024SellCRMDElizabeth HurlburtEVP280,054$7.83$660.6M-43.72%+37.47%$2.2M+0.00%Sell Now
Oct 31, 2024BuyCRMDErin MistryEVP, Chief Commercial Officer1,500$9.99$660.6M-43.72%+37.47%$15.0K+2.97%Sell Now
May 10, 2024SellCRMDJoseph TodiscoChief Executive Officer26,982$5.17$660.6M-43.72%+37.47%$139.5K-7.65%Sell Now
Mar 13, 2024BuyCRMDJoseph TodiscoChief Executive Officer13,561$3.74$660.6M-43.72%+37.47%$50.7K+4.00%Sell Now
Jan 12, 2024SellCRMDErin MistryChief Commercial Officer4,389$3.47$660.6M-43.72%+37.47%$15.2K-2.83%Sell Now
Jan 12, 2024SellCRMDElizabeth Masson-HurlburtEVP, Head of Clinical Ops.4,603$3.47$660.6M-43.72%+37.47%$16.0K-2.91%Sell Now
Jan 12, 2024SellCRMDMatthew T DavidChief Financial Officer5,216$3.47$660.6M-43.72%+37.47%$18.1K-3.41%Sell Now
Jan 12, 2024SellCRMDJoseph TodiscoChief Executive Officer13,781$3.47$660.6M-43.72%+37.47%$47.8K-2.22%Sell Now
Nov 17, 2023BuyCRMDErin MistryChief Commercial Officer1,000$4.00$660.6M-43.72%+37.47%$4.0K+25.64%Sell Now
Sep 8, 2023BuyCRMDJoseph TodiscoChief Executive Officer10,000$3.71$660.6M-43.72%+37.47%$37.1K+4.77%Sell Now